The Zacks Analyst Blog Highlights InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare
Zacks via Yahoo Finance· 2 hours agoStocks recently featured in the blog include: InMode INMD, Johnson & Johnson JNJ, Intuitive Surgical...
Johnson & Johnson: The Ultimate Bull Trap Is Here (NYSE:JNJ)
Seeking Alpha· 2 hours agoJohnson & Johnson (NYSE:JNJ) is one of the world's largest multinational healthcare corporations,...
Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock
Zacks via Yahoo Finance· 23 hours agoJohnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you...
Johnson & Johnson (NYSE:JNJ) Seems To Use Debt Quite Sensibly
Simply Wall St. via Yahoo Finance· 1 day agoSo it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very...
Johnson & Johnson (JNJ) Stock Moves -0.1%: What You Should Know
Zacks via Yahoo Finance· 6 days agoJohnson & Johnson (JNJ) closed the most recent trading day at $156.66, moving -0.1% from the...
Is There An Opportunity With Johnson & Johnson's (NYSE:JNJ) 22% Undervaluation?
Simply Wall St. via Yahoo Finance· 5 days agoUsing the most recent financial data, we'll take a look at whether the stock is fairly priced by...
Tylenol parent Kenvue can capitalize on consumer self-care trends, JPMorgan says
CNBC· 2 hours agoKenvue is well-positioned for accelerated growth following its separation from parent company...
Should iShares Core High Dividend ETF (HDV) Be on Your Investing Radar?
Zacks via Yahoo Finance· 2 hours agoLooking at individual holdings, Exxon Mobil Corp (XOM) accounts for about 8.61% of total assets,...
Better Buy: Medtronic vs. Johnson & Johnson
Motley Fool· 6 days agoMedtronic (NYSE: MDT) and Johnson & Johnson (NYSE: JNJ) are perfect examples of this type of winning long-term investment. Medtronic sells devices...
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Reuters· 7 days agoJohnson & Johnson (JNJ.N) has settled its lawsuit over Amgen Inc's (AMGN.O) proposed biosimilar...